corinne_13d-cytodyn.htm
CUSIP No. 23283M 10 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Cytodyn, Inc.
(Name of Issuer)
Common Stock, no par value
(Title of Class of Securities)
23283M 10 1
(CUSIP Number)
Law Offices of Joseph P. Bartlett, Esq.
1900 Avenue of the Stars, Suite 20th Floor
Los Angeles, CA 90067
(310) 201-7553
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
May 5, 2011
(Date of Event which Requires Filing of this Statement)
If the reporting person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /.
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7(b) for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
1. Names of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
|
|
Corinne Allen
|
| |
|
2. Check the Appropriate Box if a Member of a Group
|
|
(A) o
|
|
(B) o
|
| |
|
3. SEC Use Only
|
| |
|
4. Source of Funds
|
| |
| PF |
| |
|
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
|
6. Citizenship or Place of Organization
|
| |
| U.S. |
| |
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With:
|
7. Sole Voting Power
|
| 1,417,204 |
| |
|
8. Shared Voting Power
|
| -0- |
| |
|
9. Sole Dispositive Power
|
| 1,417,204 |
| |
|
10. Shared Dispositive Power
|
| -0- |
| |
|
11. Aggregate Amount Beneficially Owned by Each Reporting Person
|
| 1,417,204 |
| |
|
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares o
|
|
|
|
13. Percent of Class Represented by Amount in Row (11)
|
| 6.5%(1) |
| |
|
14. Type of Reporting Person
|
| IN |
_________________
(1) Based on 21,797,396 shares of Common Stock outstanding, as reported in the Company’s Form 10-Q filed 10/07/2011. See Item 5 for a more detailed description.
Item 1. Security and Issuer
Issuer: Cytodyn, Inc.
Security: Common Stock, no par value (“Common Stock”)
Item 2. Identity and Background
(a) This Statement is being filed by Corinne Allen (the “Reporting Person”).
(b) The Reporting Person’s business address is PO Box 66, Glorieta, NM 87535.
(c) The Reporting Person is a homemaker.
(d) The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) The Reporting Person has not, during the past five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f) The Reporting Person is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration
All shares of Common Stock were purchased using personal funds
Item 4. Purpose of Transaction
The shares of Common Stock were purchased by the Reporting Person in connection with the founding of the Company. The Reporting Person resigned as an employee of the Company on March 17, 2011. The Reporting Person has no plans or proposals which relate to or which would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Persons retains right to modify plans with respect to the transactions described in this Schedule 13D, to vote, acquire or dispose of securities of the Issuer and to formulate plans and proposals which could result in the occurrence of any such events, subject to applicable laws and regulations.
Item 5. Interest in Securities of the Issuer
(a) As of the date of this Schedule 13D, the Reporting Person beneficially owns 1,417,204 shares of Common Stock, representing 6.5% of the shares of Common Stock (based on the number of shares of Common Stock issued and outstanding as reported on the Issuer’s 10-Q filed on 10/07/2011).
(b) The Reporting Person has sole voting and dispositive power with respect to all shares of Common Stock beneficially owned.
(c) The only transactions since the date 60 days following the event reported has been (a) the receipt of a gift of 200,000 shares (100,000 shares on May 5, 2011, and 100,000 shares on May 17, 2011) from the Reporting Person’s father, Al Allen and the following open market sales:
|
Beginning Reporting Shares
|
|
|
1,038,071
|
|
|
| |
|
|
|
|
|
|
|
|
Date
|
|
Security Transaction
|
|
|
Amt of Shs
|
|
Net Shs
|
|
May 3, 2011
|
|
Gift from Al
|
|
|
100,000
|
|
1,138,071
|
|
May 17, 2011
|
|
Gift from Al
|
|
|
100,000
|
|
1,238,071
|
|
May 6, 2011
|
|
Open Market Sale
|
|
|
(10,000)
|
|
1,228,071
|
|
May 9, 2011
|
|
Open Market Sale
|
|
|
(5,000)
|
|
1,223,071
|
|
May 10, 2011
|
|
Open Market Sale
|
|
|
(5,000)
|
|
1,218,071
|
|
May 11, 2011
|
|
Open Market Sale
|
|
|
(4,000)
|
|
1,214,071
|
|
May 12, 2011
|
|
Open Market Sale
|
|
|
(25,000)
|
|
1,189,071
|
|
May 18, 2011
|
|
Open Market Sale
|
|
|
(10,000)
|
|
1,179,071
|
|
May 19, 2011
|
|
Open Market Sale
|
|
|
(10,000)
|
|
1,169,071
|
|
May 20, 2011
|
|
Open Market Sale
|
|
|
(15,000)
|
|
1,154,071
|
|
May 23, 2011
|
|
Open Market Sale
|
|
|
(10,000)
|
|
1,144,071
|
|
May 24, 2011
|
|
Open Market Sale
|
|
|
(6,000)
|
|
1,138,071
|
|
May 26, 2011
|
|
Open Market Sale
|
|
|
(10,000)
|
|
1,128,071
|
|
May 27, 2011
|
|
Open Market Sale
|
|
|
(9,400)
|
|
1,118,671
|
|
May 31, 2011
|
|
Open Market Sale
|
|
|
(10,000)
|
|
1,108,671
|
|
June 1, 2011
|
|
Open Market Sale
|
|
|
(9,000)
|
|
1,099,671
|
|
June 7, 2011
|
|
Open Market Sale
|
|
|
(8,000)
|
|
1,091,671
|
|
June 9, 2011
|
|
Open Market Sale
|
|
|
(3,600)
|
|
1,088,071
|
|
July 27, 2011
|
|
Open Market Sale
|
|
|
(16,230)
|
|
1,071,841
|
|
August 2, 2011
|
|
Open Market Sale
|
|
|
(14,000)
|
|
1,057,841
|
|
August 8, 2011
|
|
Open Market Sale
|
|
|
(4,500)
|
|
1,053,341
|
|
August 12, 2011
|
|
Open Market Sale
|
|
|
(1,000)
|
|
1,052,341
|
|
August 16, 2011
|
|
Open Market Sale
|
|
|
(1,500)
|
|
1,050,841
|
|
August 17, 2011
|
|
Open Market Sale
|
|
|
(1,000)
|
|
1,049,841
|
|
Sep 12,2011
|
|
Open Market Sale
|
|
|
(11,770)
|
|
1,038,071
|
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
None
Item 7. Material to Be Filed as Exhibits
None
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct and agrees that this statement may be filed jointly with the other undersigned parties.
Dated: December 5, 2011
/s/ Corinne Allen
Corinne Allen
4